← Leaderboards
Hongyan Guo
Louisiana State Univ Hsc Shreveport
$1,222,240
Attributed
$1,222,240
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $644.5K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,222,240 · 3
By mechanism
R21$817,540 · 2
P20$404,700 · 1
Top collaborators
No co-investigators on record.
Most similar at Louisiana State Univ Hsc Shreveport
Same institution · by research overlap
- Md. Shenuarin Bhuiyan$4,885,676
Others in their field
Other Rising Stars on “Virus”
- Gene Garrard Olinger · University Of Texas Med Br Galveston$23,000,000
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Kevin V Grimes · Stanford University$14,783,804
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Carolina Porras · Fundacion Inciensa$10,814,023
- Michael George Natchus · Emory University$10,548,554
Research focus
VirusHerpesvirus 1Mouse ModelCellsCytoplasmInflammatoryMelanoma TumorLeftMalignant NeoplasmsImmunotherapyImmune ResponseCancer ImmunotherapyMediatingMelanomaInfectionCell NucleusAdjuvantCell DeathApoptosisImmune Checkpoint BlockadeImmunogenicImmunogenicityExtracellular SpaceImmune Cell Infiltrate
Grant awards (5)
Boosting Oncolytic HSV Immunotherapy by Enabling Necroptosis$416,040
R21 · FY2025 · CA · contact PI
Oncolytic Herpes Simplex Virus (HSV)1 as adjuvants for melanoma$228,465
P20 · FY2025 · GM · contact PI
Role of receptor-interacting serine/threonine-protein kinase 3 (RIPK3) in Herpes Simplex Virus (HSV) Encephalitis$182,500
R21 · FY2024 · AI · contact PI
Oncolytic Herpes Simplex Virus (HSV)1 as adjuvants for melanoma$176,235
P20 · FY2024 · GM · contact PI
Role of receptor-interacting serine/threonine-protein kinase 3 (RIPK3) in Herpes Simplex Virus (HSV) Encephalitis$219,000
R21 · FY2023 · AI · contact PI